What Are the Prescription Medications for PBC Itching?
At a Glance
Severe itching in PBC requires specific prescription medications because it is driven by bile acids, not histamines. Treatment follows a step-up approach, typically starting with cholestyramine, and can advance to rifampicin, naltrexone, sertraline, or newer options like seladelpar.
Severe itching (pruritus) in Primary Biliary Cholangitis (PBC) can be physically exhausting and deeply disruptive to your sleep and quality of life. When over-the-counter allergy medications aren’t enough, your doctor can prescribe stronger, targeted therapies. Because the itch in PBC is driven by how your liver processes bile rather than by an allergic histamine reaction, standard allergy pills often fall short. Medical guidelines outline a specific “step-up” treatment ladder for PBC-related itching, starting with medications that bind to bile acids and advancing to other options if your itch persists [1][2].
Step 1: Bile Acid Sequestrants
The first step for treating PBC itching is typically a bile acid sequestrant, most commonly cholestyramine (or colestyramine) [3][4]. These medications work in your digestive tract to bind to bile acids, allowing your body to eliminate them rather than reabsorbing them into your bloodstream.
Cholestyramine comes as a powder that you mix with a liquid or soft food. It can take a few days to a couple of weeks to notice relief. While it is generally well-tolerated, it can bind to other medications and prevent your body from absorbing them [3]. Because of this, it is crucial that you carefully time your doses. Standard hepatology guidance recommends taking your foundational PBC treatments, like Ursodeoxycholic acid (UDCA), at least 1 hour before or 4 to 6 hours after your cholestyramine dose to ensure your liver medication is fully absorbed [5].
Step 2: Rifampicin
If cholestyramine does not provide enough relief, your doctor may suggest moving to the second step: rifampicin [3][6]. Originally developed as an antibiotic, rifampicin is highly effective for cholestatic itch, with many patients feeling relief within a few weeks [4]. It works in the liver by activating certain pathways that change how bile acids are processed.
Because rifampicin is a strong medication, it requires close medical supervision. It carries a risk of liver toxicity (hepatotoxicity), meaning it can cause liver injury in some people [7][8]. If you start rifampicin, your care team will need to monitor your liver function through regular blood tests, especially during the first few months [9]. Additionally, rifampicin can interact with many other drugs by speeding up how quickly your body breaks them down, so your doctor will need to review your entire medication list before you start taking it [10].
Step 3: Naltrexone
The third step is an oral opiate antagonist called naltrexone [1][6]. While PBC itch is complex, it is believed that the condition may elevate naturally occurring, opioid-like substances in your brain that trigger the sensation of itching. Naltrexone works by blocking these specific signals [11][12].
Doctors usually start naltrexone at a very low dose to help your body adjust [11]. Starting at a high dose can sometimes cause a temporary set of side effects that feel like opioid withdrawal, such as fatigue, restlessness, or trouble sleeping [13][14]. It may take a few weeks to reach a dose that provides relief. Because naltrexone blocks opioid receptors, it will also block the pain-relieving effects of opioid medications [15]. You should carry a medical alert card noting you take naltrexone in case you ever need emergency pain management or surgery.
Step 4: Sertraline
If the itch remains stubbornly resistant, your doctor may recommend sertraline, a Selective Serotonin Reuptake Inhibitor (SSRI) [1][4]. Sertraline is traditionally used as an antidepressant, but it can also alter how itch signals are transmitted in the brain [2].
Like other SSRIs, sertraline is not a quick fix; it typically takes several weeks of daily use to see improvements in your itching [2]. When starting the medication, some people experience mild, temporary side effects such as nausea or changes in their sleep patterns [1].
Newer Therapies for Refractory Itch
If the standard step-up therapies do not work, there are newer options available. For example, seladelpar was recently approved specifically for PBC and has been shown to improve both liver biomarkers and severe itching [16]. Other emerging medications, such as linerixibat (a drug that blocks bile acid reabsorption in the intestine), are currently being studied in clinical trials and show significant promise for treating stubborn PBC itch [17]. Your hepatologist can help determine if you are a candidate for these newer or investigational treatments.
Common questions in this guide
Why do regular allergy pills not work for PBC itching?
How should I time my cholestyramine dose if I take UDCA?
Are there risks to taking rifampicin for my liver itch?
Will naltrexone interfere with emergency pain medications?
What happens if the standard medications don't stop my PBC itching?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.If I start cholestyramine, how exactly should I time my doses around my UDCA and other daily medications?
- 2.What is your protocol for monitoring my liver function through blood tests if we decide to try rifampicin?
- 3.How long should I try each medication step before we decide it isn't working and move to the next option?
- 4.What should my emergency plan be for pain management if I am taking naltrexone and require surgery or have an accident?
- 5.Am I a candidate for recently approved therapies like seladelpar, or perhaps a clinical trial for my itching?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (17)
- 1
Treatment of Pruritus Secondary to Liver Disease.
Düll MM, Kremer AE
Current gastroenterology reports 2019; (21(9)):48 doi:10.1007/s11894-019-0713-6.
PMID: 31367993 - 2
Pathogenesis and Management of Pruritus in PBC and PSC.
Kremer AE, Namer B, Bolier R, et al.
Digestive diseases (Basel, Switzerland) 2015; (33 Suppl 2()):164-75 doi:10.1159/000440829.
PMID: 26641452 - 3
Pruritus in Chronic Liver Disease.
Selim R, Ahn J
Clinics in liver disease 2023; (27(1)):47-55 doi:10.1016/j.cld.2022.08.011.
PMID: 36400466 - 4
Cholestatic Itch Management.
Mittal A
Current problems in dermatology 2016; (50()):142-8 doi:10.1159/000446057.
PMID: 27578083 - 5
Evaluating the real-world safety of cholestyramine for the treatment of hyperlipidemia: disproportionality analysis of FAERS data.
Li Q, Fan M, Gao A, Qin L
Frontiers in medicine 2026; (13()):1765949 doi:10.3389/fmed.2026.1765949.
PMID: 41756368 - 6
Management of Chronic Hepatic Itch.
Düll MM, Kremer AE
Dermatologic clinics 2018; (36(3)):293-300 doi:10.1016/j.det.2018.02.008.
PMID: 29929600 - 7
Farnesoid X Receptor: Effective alleviation of rifampicin -induced liver injury.
Zhou Y, Li M, Cao Y, et al.
International immunopharmacology 2024; (139()):112799 doi:10.1016/j.intimp.2024.112799.
PMID: 39068755 - 8
Inhibition of HSPA8 by rifampicin contributes to ferroptosis via enhancing autophagy.
Zhou J, Tan Y, Hu L, et al.
Liver international : official journal of the International Association for the Study of the Liver 2022; (42(12)):2889-2899 doi:10.1111/liv.15459.
PMID: 36254713 - 9
Study on the associations between liver damage and antituberculosis drug rifampicin and relative metabolic enzyme gene polymorphisms.
Su Q, Liu Q, Liu J, et al.
Bioengineered 2021; (12(2)):11700-11708 doi:10.1080/21655979.2021.2003930.
PMID: 34872459 - 10
Pharmacokinetics of pyrazinamide during the initial phase of tuberculous meningitis treatment.
Stemkens R, Litjens CHC, Dian S, et al.
International journal of antimicrobial agents 2019; (54(3)):371-374 doi:10.1016/j.ijantimicag.2019.06.010.
PMID: 31202922 - 11
Naltrexone for cholestatic itch: a systematic review.
Murray-Brown FL
BMJ supportive & palliative care 2021; (11(2)):217-225 doi:10.1136/bmjspcare-2020-002801.
PMID: 33692114 - 12
Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications.
Elmariah S, Chisolm S, Sciascia T, Kwatra SG
JAAD international 2022; (7()):156-163 doi:10.1016/j.jdin.2022.03.007.
PMID: 35497636 - 13
Clinical Efficacy and Safety of Naltrexone Combination Therapy in Older Patients with Severe Pruritus.
Lee J, Shin JU, Noh S, et al.
Annals of dermatology 2016; (28(2)):159-63 doi:10.5021/ad.2016.28.2.159.
PMID: 27081261 - 14
Utility of Naltrexone Treatment for Chronic Inflammatory Dermatologic Conditions: A Systematic Review.
Ekelem C, Juhasz M, Khera P, Mesinkovska NA
JAMA dermatology 2019; (155(2)):229-236 doi:10.1001/jamadermatol.2018.4093.
PMID: 30484835 - 15
The Utilization of Low Dose Naltrexone for Chronic Pain.
Poliwoda S, Noss B, Truong GTD, et al.
CNS drugs 2023; (37(8)):663-670 doi:10.1007/s40263-023-01018-3.
PMID: 37505425 - 16
Long-Term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study Results.
Levy C, Trivedi PJ, Kowdley KV, et al.
The American journal of gastroenterology 2025; doi:10.14309/ajg.0000000000003603.
PMID: 40553148 - 17
This page provides educational information about prescription options for PBC-related itching. Always consult your hepatologist or care team before starting, stopping, or changing any medications.
Get notified when new evidence is published on Primary biliary cholangitis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.